Search research articles
Contact Us
Filters
Showing results (101-110 of 158) with videos related to
Page
of 16
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 7, 2010
Erlotinib in combination with pemetrexed for patients with advanced non-small-cell lung cancer (NSCLC): a phase I dose-finding study
M Ranson, M Reck, A Anthoney, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1991
MMAF for advanced gastric cancer
H Anderson, J H Scarffe, M Ranson, et al.
Scientific Reports
|
June 22, 2021
Interaction between genetic predisposition, smoking, and dementia risk: a population-based cohort study
Na Zhang, Janice M Ranson, Zhi-Jie Zheng, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 1990
Five year follow-up and dose delivery analysis of cisplatin, iproplatin or carboplatin in combination with cyclophosphamide in advanced ovarian carcinoma
H Gurney, D Crowther, H Anderson, et al.
International Journal of Cancer
|
September 29, 2000
Urokinase-type plasminogen activator and its receptor in colorectal cancer: independent prognostic factors of metastasis and cancer-specific survival and potential therapeutic targets
J L Yang, D q Seetoo, Y Wang, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 23, 2003
Phase II study of exatecan mesylate (DX-8951f) as first line therapy for advanced non-small cell lung cancer
J P Braybrooke, M Ranson, C Manegold, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 1993
A randomised dose intensity study in ovarian carcinoma comparing chemotherapy given at four week intervals for six cycles with half dose chemotherapy given for twelve cycles
D Murphy, D Crowther, J Renninson, et al.
Bone Marrow Transplantation
|
June 1, 1994
Rapid haematological recovery after high-dose consolidation chemotherapy with peripheral blood progenitor cells (PBPC) as sole source of support collected at a single apheresis
M E Van Hoef, M Ranson, G R Morgenstern, et al.
Annals of Vascular Surgery
|
August 21, 2007
Regional nerve block allows for optimization of planning in the creation of arteriovenous access for hemodialysis by improving superficial venous dilatation
I A Laskowski, B Muhs, C R Rockman, et al.
The HUGO Journal
|
December 2, 2011
Current status and future potential of somatic mutation testing from circulating free DNA in patients with solid tumours
K L Aung, R E Board, G Ellison, et al.
Page
of 16
Search research articles
Search
Showing results (101-110 of 158) with videos related to
Sort By:
Page
of 16
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 7, 2010
Erlotinib in combination with pemetrexed for patients with advanced non-small-cell lung cancer (NSCLC): a phase I dose-finding study
M Ranson, M Reck, A Anthoney, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1991
MMAF for advanced gastric cancer
H Anderson, J H Scarffe, M Ranson, et al.
Scientific Reports
|
June 22, 2021
Interaction between genetic predisposition, smoking, and dementia risk: a population-based cohort study
Na Zhang, Janice M Ranson, Zhi-Jie Zheng, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 1990
Five year follow-up and dose delivery analysis of cisplatin, iproplatin or carboplatin in combination with cyclophosphamide in advanced ovarian carcinoma
H Gurney, D Crowther, H Anderson, et al.
International Journal of Cancer
|
September 29, 2000
Urokinase-type plasminogen activator and its receptor in colorectal cancer: independent prognostic factors of metastasis and cancer-specific survival and potential therapeutic targets
J L Yang, D q Seetoo, Y Wang, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 23, 2003
Phase II study of exatecan mesylate (DX-8951f) as first line therapy for advanced non-small cell lung cancer
J P Braybrooke, M Ranson, C Manegold, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 1993
A randomised dose intensity study in ovarian carcinoma comparing chemotherapy given at four week intervals for six cycles with half dose chemotherapy given for twelve cycles
D Murphy, D Crowther, J Renninson, et al.
Bone Marrow Transplantation
|
June 1, 1994
Rapid haematological recovery after high-dose consolidation chemotherapy with peripheral blood progenitor cells (PBPC) as sole source of support collected at a single apheresis
M E Van Hoef, M Ranson, G R Morgenstern, et al.
Annals of Vascular Surgery
|
August 21, 2007
Regional nerve block allows for optimization of planning in the creation of arteriovenous access for hemodialysis by improving superficial venous dilatation
I A Laskowski, B Muhs, C R Rockman, et al.
The HUGO Journal
|
December 2, 2011
Current status and future potential of somatic mutation testing from circulating free DNA in patients with solid tumours
K L Aung, R E Board, G Ellison, et al.
Page
of 16